deferasirox has been researched along with Chronic Kidney Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doery, JC; Kaplan, Z; Kerr, PG; Yii, E | 1 |
| Beydoun, HG; Saliba, AN; Taher, AT | 1 |
| Brewster, UC; McPhedran, P; Yusuf, B | 1 |
| Chen, YM; Huang, CC; Kuo, CC; Tsai, CW; Yang, FJ | 1 |
4 other study(ies) available for deferasirox and Chronic Kidney Failure
| Article | Year |
|---|---|
Use of deferasirox (Exjade) for iron overload in peritoneal dialysis patients.
Topics: Benzoates; beta-Thalassemia; Deferasirox; Dialysis Solutions; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Treatment Outcome; Triazoles | 2018 |
Deferasirox in thalassemia patients with end-stage renal disease.
Topics: Benzoates; Deferasirox; Female; Humans; Iron Chelating Agents; Kidney Failure, Chronic; Male; Middle Aged; Thalassemia; Triazoles | 2016 |
Hypocalcemia in a dialysis patient treated with deferasirox for iron overload.
Topics: Adult; Anemia, Sickle Cell; Benzoates; Deferasirox; Erythropoietin; Female; Humans; Hypertension; Hypocalcemia; Iron Chelating Agents; Iron Overload; Kidney Failure, Chronic; Peritoneal Dialysis; Transfusion Reaction; Triazoles | 2008 |
The administration of deferasirox in an iron-overloaded dialysis patient.
Topics: Benzoates; Deferasirox; Hemochromatosis; Humans; Iron Chelating Agents; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Triazoles | 2013 |